Table 3. Comparison of biological abnormalities between critically and non-critically ill COVID-19 pneumonia patient groups.
| Biological abnormalities | Total number (N=456) | Non-critical group (N=341) | Critical group (N=115) | p-value |
|---|---|---|---|---|
| Hyperleucocytosis, N (%) | 110 (24.1) | 80 (23.5) | 30 (26.1) | 0.569 |
| Lymphopenia, N (%) | 355 (77.9) | 253 (76) | 102 (89.5) | 0.002 |
| Neutrophilia, N (%) | 155 (34.6) | 113 (34) | 42 (36.8) | 0.573 |
| Thrombocytopenia, N (%) | 59 (12.9) | 37 (11.1) | 22 (19.5) | 0.023 |
| Increased CRP, N (%) | 424 (93.5) | 315 (96) | 109 (98.2) | 0.375 |
| D-Dimer > 1000 ng/ml, N (%) | 50 (40.8) | 31 (31.3) | 19 (51.4) | 0.031 |
| Increased blood urea nitrogen, N (%) | 186 (40.8) | 135 (39.6) | 51 (44.3) | 0.369 |
| Increased aminotransferase, N (%) | 157 (39.5) | 116 (39.7) | 41 (39) | 1 |
| Increased Creatine Kinase, N (%) | 55 (24.2) | 31 (18.6) | 24 (40) | 0.001 |
| Increased Lactate dehydrogenase, N (%) | 190 (41.6) | 135 (39.5) | 55 (47.8) | 1 |
| Increased tropnin, N (%) | 21 (18) | 9 (10.5) | 12 (38.7) | <0.001 |